Its a little-known consequence of the obesity drug boom, according to doctors who caution eager patients not to expect one-size-fits-all results
Mounjaro is similar to Ozempic, but it targets both GIP and GLP-1 receptors
When digestion slows (such as on Wegovy), it can cause symptoms such as bloating, acid reflux or heartburn , and indigestion
A review published in Obesity Reviews in 2024 highlights that long-term GLP-1 users present a risk profile comparable to patients post-bariatric surgery regarding these micronutrients
(2000) Heffernan, Jiang, Thorburn, and Ng evaluated the metabolic effects of orally administered AOD-9604 in rodent models and the lipolytic activity of the compound on isolated human adipose tissue ex vivo
It improves blood flow, can help with blood pressure management (TRT sometimes elevates BP), and enhances nutrient delivery to muscles